The current approach to the diagnosis of myelodysplastic syndromes

Olga K. Weinberg, Robert P. Hasserjian

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Myelodysplastic syndromes (MDS) are heterogeneous hematopoietic neoplasms that share key clinical and biologic features, including peripheral blood cytopenias, morphologic dysplasia, ineffective and clonal hematopoiesis, and a variable risk of transformation to acute myeloid leukemia. Diagnostic evaluation of MDS relies on morphologic assessment of the peripheral blood and bone marrow, conventional cytogenetics, and exclusion of secondary causes of dysplasia. The diagnosis of MDS has important clinical consequences, but it can be challenging and requires distinction from mimics. In this review, the principles of bone marrow interpretation with respect to the diagnosis and classification of MDS in the current era will be discussed, including accurate morphologic interpretation, use of flow cytometry and immunohistochemistry, appropriate use of cytogenetics, and the emerging role of molecular genetics.

Original languageEnglish (US)
Pages (from-to)15-21
Number of pages7
JournalSeminars in hematology
Issue number1
StatePublished - Jan 2019
Externally publishedYes


  • Cytogenetic findings
  • Diagnosis
  • Etiology
  • Mutations
  • Myelodysplastic syndrome
  • Prognosis

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'The current approach to the diagnosis of myelodysplastic syndromes'. Together they form a unique fingerprint.

Cite this